Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincenzo Marotta

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Endocrine|April 2, 2013
Radioiodide induces apoptosis in human thyroid tissue in cultureEleonora Russo, Anna Guerra, Vincenzo Marotta, et al.
Neuroendocrinology|February 4, 2025
Cabozantinib in the Treatment of Neuroendocrine Neoplasms: Insights across Different Tumor OriginsGiovanni Vitale, Ilona Rybinska, Giulia Arrivi, et al.
Clinical Endocrinology|March 9, 2013
BRAF mutation positive papillary thyroid carcinoma is less advanced when Hashimoto's thyroiditis lymphocytic infiltration is presentVincenzo Marotta, Anna Guerra, Maria C Zatelli, et al.
The Journal of Clinical Endocrinology and Metabolism|April 18, 2012
A high percentage of BRAFV600E alleles in papillary thyroid carcinoma predicts a poorer outcomeAnna Guerra, Laura Fugazzola, Vincenzo Marotta, et al.
Environmental Pollution (Barking, Essex : 1987)|October 28, 2022
Exposure to Bisphenol A increases malignancy risk of thyroid nodules in overweight/obese patientsVincenzo Marotta, Lucia Grumetto, Ilaria Neri, et al.
Clinical Endocrinology|August 12, 2015
Benign thyroid nodules with RAS mutation grow fasterAlessandro Puzziello, Anna Guerra, Alessia Murino, et al.
Endocrine|December 4, 2012
BRAF (V600E) associates with cytoplasmatic localization of p27kip1 and higher cytokeratin 19 expression in papillary thyroid carcinomaAnna Guerra, Vincenzo Marotta, Maurilio Deandrea, et al.
Critical Reviews in Oncology/Hematology|May 17, 2021
Kinase-inhibitors for iodine-refractory differentiated thyroid cancer: still far from a structured therapeutic algorithmVincenzo Marotta, Maria Grazia Chiofalo, Francesca Di Gennaro, et al.
The Journal of Clinical Endocrinology and Metabolism|December 16, 2011
The primary occurrence of BRAF(V600E) is a rare clonal event in papillary thyroid carcinomaAnna Guerra, Maria Rosaria Sapio, Vincenzo Marotta, et al.
Clinical Endocrinology|September 27, 2012
Sorafenib in advanced iodine-refractory differentiated thyroid cancer: efficacy, safety and exploratory analysis of role of serum thyroglobulin and FDG-PETVincenzo Marotta, Valeria Ramundo, Luigi Camera, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Endocrine|April 2, 2013
Radioiodide induces apoptosis in human thyroid tissue in cultureEleonora Russo, Anna Guerra, Vincenzo Marotta, et al.
Neuroendocrinology|February 4, 2025
Cabozantinib in the Treatment of Neuroendocrine Neoplasms: Insights across Different Tumor OriginsGiovanni Vitale, Ilona Rybinska, Giulia Arrivi, et al.
Clinical Endocrinology|March 9, 2013
BRAF mutation positive papillary thyroid carcinoma is less advanced when Hashimoto's thyroiditis lymphocytic infiltration is presentVincenzo Marotta, Anna Guerra, Maria C Zatelli, et al.
The Journal of Clinical Endocrinology and Metabolism|April 18, 2012
A high percentage of BRAFV600E alleles in papillary thyroid carcinoma predicts a poorer outcomeAnna Guerra, Laura Fugazzola, Vincenzo Marotta, et al.
Environmental Pollution (Barking, Essex : 1987)|October 28, 2022
Exposure to Bisphenol A increases malignancy risk of thyroid nodules in overweight/obese patientsVincenzo Marotta, Lucia Grumetto, Ilaria Neri, et al.
Clinical Endocrinology|August 12, 2015
Benign thyroid nodules with RAS mutation grow fasterAlessandro Puzziello, Anna Guerra, Alessia Murino, et al.
Endocrine|December 4, 2012
BRAF (V600E) associates with cytoplasmatic localization of p27kip1 and higher cytokeratin 19 expression in papillary thyroid carcinomaAnna Guerra, Vincenzo Marotta, Maurilio Deandrea, et al.
Critical Reviews in Oncology/Hematology|May 17, 2021
Kinase-inhibitors for iodine-refractory differentiated thyroid cancer: still far from a structured therapeutic algorithmVincenzo Marotta, Maria Grazia Chiofalo, Francesca Di Gennaro, et al.
The Journal of Clinical Endocrinology and Metabolism|December 16, 2011
The primary occurrence of BRAF(V600E) is a rare clonal event in papillary thyroid carcinomaAnna Guerra, Maria Rosaria Sapio, Vincenzo Marotta, et al.
Clinical Endocrinology|September 27, 2012
Sorafenib in advanced iodine-refractory differentiated thyroid cancer: efficacy, safety and exploratory analysis of role of serum thyroglobulin and FDG-PETVincenzo Marotta, Valeria Ramundo, Luigi Camera, et al.
Pageof 5